Wells Fargo & Company Boosts Celldex Therapeutics (NASDAQ:CLDX) Price Target to $37.00
Celldex Therapeutics (NASDAQ:CLDX – Free Report) had its target price increased by Wells Fargo & Company from $35.00 to $37.00 in a report published on Monday morning, Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the biopharmaceutical company’s stock. Other research analysts have also issued reports about the company. HC […]
More Stories
Arctic Star Exploration (CVE:ADD) Stock Price Up 50% – Still a Buy?
Arctic Star Exploration Corp. (CVE:ADD – Get Free Report) shares rose 50% on Saturday . The company traded as high...
PHX Minerals (NYSE:PHX) & EQT (NYSE:EQT) Financial Contrast
EQT (NYSE:EQT – Get Free Report) and PHX Minerals (NYSE:PHX – Get Free Report) are both oils/energy companies, but which...
Invesque (TSE:IVQ.U) Stock Price Up 20% – What’s Next?
Shares of Invesque Inc (TSE:IVQ.U – Get Free Report) were up 20% during mid-day trading on Saturday . The stock...
GGL Resources (CVE:GGL) Stock Price Up 33.3% – Should You Buy?
GGL Resources Corp. (CVE:GGL – Get Free Report)’s share price rose 33.3% during mid-day trading on Saturday . The stock...
Chanson International (NASDAQ:CHSN) versus Nestlé (OTCMKTS:NSRGY) Critical Survey
Nestlé (OTCMKTS:NSRGY – Get Free Report) and Chanson International (NASDAQ:CHSN – Get Free Report) are both consumer staples companies, but...
Arctic Star Exploration (CVE:ADD) Trading Up 50% – Still a Buy?
Shares of Arctic Star Exploration Corp. (CVE:ADD – Get Free Report) shot up 50% during mid-day trading on Saturday ....